Alogliptin Benzoate

DRUG3 trials

Sponsors

Takeda

Conditions

Diabetes MellitusDiabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 3

Phase 3 Alogliptin Pediatric Study

CompletedNCT02856113

TakedaDiabetes Mellitus, Type 2

Start: 2016-10-14End: 2022-02-14Updated: 2022-10-19

Unknown Phase

An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2

CompletedNCT02756832

TakedaDiabetes Mellitus

Start: 2016-09-20End: 2018-04-28Updated: 2019-07-10

A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea

CompletedNCT04980040

TakedaType 2 Diabetes Mellitus

Start: 2014-04-19End: 2019-08-30Updated: 2022-04-05

Related Papers

A Randomized Phase 3 Study Evaluating the Efficacy and Safety of Alogliptin in Pediatric Participants with Type 2 Diabetes Mellitus

Diabetes Therapy2025-03-041 citations